Ironwood Pharmaceuticals (IRWD) Tax Provisions (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Tax Provisions across 9 years of filings, most recently posting $24.4 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at $24.4 million, up 2118.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.5 million (up 340.6% YoY), and the FY2025 annual result was $5.2 million, up 239.49% from the prior year.
• Tax Provisions came in at $24.4 million for Q1 2026 at Ironwood Pharmaceuticals, up from -$38.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $32.1 million in Q4 2023 to a low of -$46.3 million in Q4 2024.
• The 5-year median for Tax Provisions is $17.7 million (2022), against an average of $11.0 million.
• Across the five-year window, Tax Provisions soared 4325.0% in 2022 and sank 244.32% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Tax Provisions stood at $23.4 million in 2022, then surged by 37.21% to $32.1 million in 2023, then tumbled by 244.32% to -$46.3 million in 2024, then rose by 17.83% to -$38.1 million in 2025, then soared by 164.09% to $24.4 million in 2026.
• The last three Tax Provisions figures came in at $24.4 million (Q1 2026), -$38.1 million (Q4 2025), and $27.9 million (Q3 2025), per Business Quant data.